Gemcitabine: analogue of cytarabine that is metabolised given intracellularly inhibit DNA synthesis and induce apoptosis. It is active against cells in S phase. Given in the ttt of solid tumours including bladder, breast, lung, and pancreas).
Doses 1 g/m2, by infusion over 30 minutes, adjusted according to response and toxicity. b In breast cancer, given with a taxane such as paclitaxel. 1.25 g/m2 is given on days 1 and 8 of a 21 -day cycle, and adjusted according to toxicity.
Vial
1120 EGP
Gemcitabine: analogue of cytarabine that is metabolised given intracellularly inhibit DNA synthesis and induce apoptosis. It is active against cells in S phase. Given in the ttt of solid tumours including bladder, breast, lung, and pancreas).
Doses 1 g/m2, by infusion over 30 minutes, adjusted according to response and toxicity. b In breast cancer, given with a taxane such as paclitaxel. 1.25 g/m2 is given on days 1 and 8 of a 21 -day cycle, and adjusted according to toxicity.
Note: All the provided information about this drug does not substitute for consulting a doctor.